Liu, C-H <br/><br/>
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  06 2018 
 - 1690-1698 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Coinfection<br/>Drug Combinations<br/>Female<br/>HIV Infections--drug therapy<br/>Hepacivirus--isolation & purification<br/>Hepatitis C--drug therapy<br/>Heterocyclic Compounds, 4 or More Rings--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Ribavirin--therapeutic use<br/>Sofosbuvir--administration & dosage<br/>Sustained Virologic Response<br/>Taiwan<br/>Tenofovir--therapeutic use<br/>Treatment Outcome